Insulet
PODD
#1049
Rank
$21.43 B
Marketcap
$304.49
Share price
-3.62%
Change (1 day)
13.79%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

Insulet (PODD) - Total debt

Total debt on the balance sheet as of September 2025 : $1.01 Billion USD

According to Insulet's latest financial reports the company's total debt is $1.01 Billion USD. A companyโ€™s total debt is the sum of all current and non-current debts.

Insulet - Total debt on balance sheet (from 2005 to 2025)

Total debt by year

Year Total debt Change
2024-12-31$1.39 B-1.67%
2023-12-31$1.41 B1%
2022-12-31$1.40 B10.04%
2021-12-31$1.27 B20.26%
2020-12-31$1.05 B19.3%
2019-12-31$0.88 B49.98%
2018-12-31$0.59 B4.56%
2017-12-31$0.56 B70.14%
2016-12-31$0.33 B87.49%
2015-12-31$0.17 B4.61%
2014-12-31$0.16 B39.44%
2013-12-31$0.12 B2.98%
2012-12-31$0.11 B8.86%
2011-12-31$0.10 B56.32%
2010-12-31$69.43 M-28.4%
2009-12-31$96.97 M61.17%
2008-12-31$60.17 M125.56%
2007-12-31$26.67 M-8.71%
2006-12-31$29.22 M198.76%
2005-12-31$9.78 M88818.18%
2004-12-31$0.01 M0%
2003-12-31$0.01 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
ICU Medical
ICUI
$1.36 B 34.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Tandem Diabetes Care
TNDM
$0.44 B-55.73%๐Ÿ‡บ๐Ÿ‡ธ USA
DexCom
DXCM
$2.57 B 153.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
$45.79 B 4,412.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
$12.94 B 1,175.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
$28.60 B 2,719.18%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Eli Lilly
LLY
$42.50 B 4,088.67%๐Ÿ‡บ๐Ÿ‡ธ USA